// App-Quantinova.ai

: Late Breaking Abstract - Blood eosinophil count and exacerbation history in COPD: pooled analysis of 24,103 patients

Researchers

Presenter

  • Jadwiga Wedzicha

Principal Investigators

  • Salman Siddiqui

  • Peter Calverley

  • Alberto De La Hoz

  • Florian Vo

  • Helgo Magnussen

  • Klaus F. Rabe

  • Dave Singh

Medical Centers

  • National Heart and Lung Institute, Imperial College London, London, United Kingdom

  • NIHR Leicester Biomedical Research Centre: Respiratory Theme, and Department of Respiratory Sciences, University of Leicester, Leicester, United Kingdom

  • Clinical Science Centre, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom.

  • Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany,

  • Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim Am Rhein, Germany

  • Pulmonary Research Institute at LungenClinic Großhansdorf, Airway Research Center North, German Center for Lung Research, Großhansdorf, Germany,

  • LungenClinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany

  • Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Trust, Manchester, United Kingdom,

Locations

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • Tiotropium/olodaterol

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A